FDA — authorised 21 November 2017
- Application: NDA210192
- Marketing authorisation holder: VIIV HLTHCARE
- Local brand name: JULUCA
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 JULUCA in United States
FDA authorised JULUCA on 21 November 2017
Marketing authorisation
JULUCA in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease / Virology approved in United States
Frequently asked questions
Is JULUCA approved in United States?
Yes. FDA authorised it on 21 November 2017.
Who is the marketing authorisation holder for JULUCA in United States?
VIIV HLTHCARE holds the US marketing authorisation.